Verana Health Developing Qdata® Dry Eye Disease, the Largest Real-World Dataset of its Kind
April 04, 2024 09:00 ET
|
Verana Health, Inc.
SAN FRANCISCO, April 04, 2024 (GLOBE NEWSWIRE) -- Verana Health®, a digital health company dedicated to revolutionizing patient care and clinical research through real-world data (RWD), today...
VIDEO: AXIM Biotechnologies CEO Presents at Benzinga Virtual Healthcare Summit 2024
March 27, 2024 09:00 ET
|
AXIM Biotechnologies, Inc.
Company CEO John Huemoeller II Interviewed by Tony Noto on AXIM’s Diagnostic Research Programs in Dry Eye Disease and Parkinson’s SAN DIEGO, CA, March 27, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire...
Dry Eye Disease Market Size Projected to Reach USD 8.7 billion by 2031, With 4.2% CAGR: Transparency Market Research, Inc.
January 04, 2024 10:00 ET
|
Transparency Market Research
Wilmington, Delaware, United States, Jan. 04, 2024 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The dry eye disease was worth US$ 6.1 billion in 2022. In 2031, it is predicted that the...
Dry Eye Disease Market to Register Immense Growth During the Study Period (2019–2032), Estimates DelveInsight | Leading Companies - BRIM, Ocular, Iacta, AbbVie, Novartis, Kowa, Sylentis, Palatin, Yuyu, Mimetogen
December 07, 2023 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, Dec. 07, 2023 (GLOBE NEWSWIRE) -- Dry Eye Disease Market to Register Immense Growth During the Study Period (2019–2032), Estimates DelveInsight | Leading Companies - BRIM, Ocular,...
Merakris Announces Nationwide At-Your-Door Autologous Serum Tears Program
October 12, 2023 06:30 ET
|
Merakris Therapeutics
The Opticyte Tears program uses patients’ blood serum to create Autologous Serum Tears from the convenience of their homes.
AXIM® Biotechnologies Starts Shipping Revenue Generating IgE Diagnostic Validation Assays to Customers Nationwide
July 12, 2023 09:00 ET
|
AXIM Biotechnologies, Inc.
Leading Diagnostic Healthcare Company Also Announces Over 50 Initial Clinic Commitments for Its Full Diagnostic Assay Platform SAN DIEGO, CA, July 12, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire –...
Bruder Healthcare Now Exclusive Licensor of the Dry Eye Drink™ -- First and Only Ophthalmic Anti-Inflammatory Hyper-Hydrating Drink
February 13, 2023 10:00 ET
|
Bruder Healthcare
ATLANTA, Feb. 13, 2023 (GLOBE NEWSWIRE) -- Bruder Healthcare, a Hilco Vision Company, announced an exclusive licensing agreement with Baton Rouge-based Dry Eye Drink LLC, the manufacturer of a...
Glacial Multimedia Inc. and Dry Eye Access Announce a New Strategic Partnership
November 16, 2022 15:00 ET
|
Glacial Multimedia Inc.
PORTLAND, Maine, Nov. 16, 2022 (GLOBE NEWSWIRE) -- Glacial Multimedia and Dry Eye Access announce a new strategic partnership to assist eye care physicians with building their dry eye services. This...
Oyster Point Pharma to Present New Scientific Analyses at World Cornea Congress VIII
September 27, 2022 08:00 ET
|
Oyster Point Pharma, Inc.
PRINCETON, N.J., Sept. 27, 2022 (GLOBE NEWSWIRE) -- Oyster Point Pharma, Inc. (Nasdaq: OYST), (“Oyster Point Pharma”, or “the Company”), a commercial-stage biopharmaceutical company focused on the...
Oyster Point Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
September 07, 2022 17:36 ET
|
Oyster Point Pharma, Inc.
PRINCETON, N.J., Sept. 07, 2022 (GLOBE NEWSWIRE) -- Oyster Point Pharma, Inc., (Nasdaq: OYST), (“Oyster Point Pharma”, or “the Company”), a commercial-stage biopharmaceutical company focused on the...